Drug
Lubiprostone
Lubiprostone: highest development phase Phase 1, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lubiprostone NCT00934479 | Phase 1 | Other Constipation |
Latest
No recent events.
Follow Lubiprostone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.